ClinicalTrials.govcontrolled
Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)
ClinicalTrials.gov study NCT00975130. IPD Sharing: YES. Countries: 0. Publications: 4.
ShareScore
32/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 12
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 8